Novartis Kymriah® pivotal trial demonstrates strong response rates and a remarkable safety profile in relapsed or refractory follicular lymphoma

Matthew Durham
Omnidynamic Marketing

Matt Turner
Patient Affordability

Daniel Sontupe
Market Access

Liz Kane
Impactful Strategy

Stacey Gandler
Brand Nourishment

Suma Ramadas, PhD
Medical Affairs

Amy Giles
Increasing Engagement

Brenda Snow
Authentic Patient Voice

Pat Purcell
Meeting Engagement

David Linetsky
Point-of-Care Marketing

Bud Bilanich
Success Coach

Paul Theisen
Patient Acquisition

Joey Cohen
Medication Adherence

Frank Burrell
Scientific Storytelling